Letter by L. Schlemm and E. Schlemm Regarding Article, "Efficacy of Clopidogrel-Aspirin Therapy for Stroke Does Not Exist in CYP2C19 Loss-of-Function Allele Noncarriers With Overweight/Obesity"

Stroke. 2020 Mar;51(3):e54. doi: 10.1161/STROKEAHA.119.028453. Epub 2020 Feb 3.

Authors

Ludwig Schlemm¹, Eckhard Schlemm²

Affiliations

¹ Klinik und Hochschulambulanz für Neurologie, Charité - Universitätsmedizin Berlin, Germany.
² Klinik und Poliklinik für Neurologie, Kopf- und Neurozentrum, Universitätsklinikum Hamburg-Eppendorf, Germany.

PMID: 32008459
DOI: 10.1161/STROKEAHA.119.028453

No abstract available

Publication types

Letter
Comment

MeSH terms

Alleles
Aspirin
Clopidogrel*
Cytochrome P-450 CYP2C19 / genetics
Humans
Obesity
Overweight
Stroke / genetics*

Substances

Clopidogrel
CYP2C19 protein, human
Cytochrome P-450 CYP2C19
Aspirin